My vision for this forum is to interpret and explain the scientific aspects of biotech/pharma in relation to investing into a particular company. For example, when company "X" releases clinical trial data and the stock does nothing you may ask yourself why? You then read the trial data and something like "the internalization of the Erb4 receptor was not statistically significant" however "the dual dimerization with EGFR was inhibited thus resulting in decreased cellular differentiation". What does this mean? Basically, companies use these large scientific words to say what could be summed up in one sentence: The main effect of drug X did not work for what we were looking for but there are signs of drug action so we will need to continue the trial for additional data.
I look forward to interacting with those of you interested in understanding biotech/pharma.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment